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Abstract
Emergence of a new influenza strain leads to a rapid global spread of the virus due to minimal antibody immunity. Pre-
existing CD8
+ T-cell immunity directed towards conserved internal viral regions can greatly ameliorate the disease. However,
mutational escape within the T cell epitopes is a substantial issue for virus control and vaccine design. Although mutations
can result in a loss of T cell recognition, some variants generate cross-reactive T cell responses. In this study, we used reverse
genetics to modify the influenza NP336–374 peptide at a partially-solvent exposed residue (N-.A, NPN3A mutation) to assess
the availability, effectiveness and mechanism underlying influenza-specific cross-reactive T cell responses. The engineered
virus induced a diminished CD8
+ T cell response and selected a narrowed T cell receptor (TCR) repertoire within two Vb
regions (Vb8.3 and Vb9). This can be partially explained by the H-2D
bNPN3A structure that showed a loss of several contacts
between the NPN3A peptide and H-2D
b, including a contact with His155, a position known to play an important role in
mediating TCR-pMHC-I interactions. Despite these differences, common cross-reactive TCRs were detected in both the naı ¨ve
and immune NPN3A-specific TCR repertoires. However, while the NPN3A epitope primes memory T-cells that give an
equivalent recall response to the mutant or wild-type (wt) virus, both are markedly lower than wt-.wt challenge. Such
decreased CD8
+ responses elicited after heterologous challenge resulted in delayed viral clearance from the infected lung.
Furthermore, mice first exposed to the wt virus give a poor, low avidity response following secondary infection with the
mutant. Thus, the protective efficacy of cross-reactive CD8
+ T cells recognising mutant viral epitopes depend on peptide-
MHC-I structural interactions and functional avidity. Our study does not support vaccine strategies that include
immunization against commonly selected cross-reactive variants with mutations at partially-solvent exposed residues that
have characteristics comparable to NPN3A.
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Introduction
Virus-specific CD8
+ T cells play a critical role in host defence
via the production of antiviral cytokines, the direct killing of virus-
infected cells and the establishment of immunological memory [1].
The selection of CD8
+ T cells into an immune response requires
specific interaction between the T cell receptor (TCR) and virus
peptide bound to Major Histocompatibility Complex class I
(pMHC-I) molecules on the surface of infected host cells. The
processing of virus proteins into short fragments generates
thousands of peptides that might potentially form pMHC-I
epitopes, but only a few elicit CTL responses [2].
Virus escape mutants are well documented for persistent
infections and constitute a major problem for CD8
+ T cell-
mediated control and vaccine design [3,4,5,6,7,8,9]. With regard
to the influenza A viruses, mutational changes driven by CD8
+
cytotoxic T lymphocytes (CTLs) are unlikely to result in long-term
persistence within the individual, as other mechanisms (particu-
larly antibody) can ultimately mediate virus clearance [10]. Even
so, the fact that such mutants can be found in nature suggests that
influenza virus-specific CTLs are of protective value. Perhaps this
reflects that the infection of new subjects favours the selection of
mutant viruses that are more slowly controlled (and thus shed for
longer), particularly in the face of a seasonal ‘‘bottleneck’’ where
PLoS Pathogens | www.plospathogens.org 1 August 2010 | Volume 6 | Issue 8 | e1001039much of the population is already immune [11]. In humans,
influenza escape variants have been observed for CD8
+ T cell
epitopes presented in context of several HLAs, including HLA-B8,
HLA-B27 and HLA-B35 [12,13,14,15,16,17,18,19]. The immu-
nogenic peptides can be modified at an MHC anchor residue,
resulting in defective binding to the MHC-I glycoprotein, or at a
TCR contact site. Mutations at TCR contact residues lead to
partial (cross-reactive) or total (non-cross-reactive) loss of recogni-
tion by wt CD8
+ T cells [13], with some variants eliciting epitope-
specific CD8
+ T cell responses that are both novel and of
substantial magnitude [12].
Using influenza A virus infection of B6 mice [20], we showed
previously that virus variants with mutations at critical solvent-
exposed residues that are important for TCR binding can generate
effective but non-cross-reactive CD8
+ CTL responses to what are
essentially new epitopes [21,22]. This raises the possibility that it
might be worthwhile to think in terms of vaccinating against likely
virus escape mutants. The present analysis focuses on the cross-
reactive (to wt D
bNP366) CD8
+ T cell response to the mutant
D
bNPN3A epitope [22] formed by substitution of the partially
solvent exposed, and non-prominent for TCR binding, residue at
position (P) 3 of the influenza NP366–374 peptide [21,23]. The
findings have implications for vaccines to combat virus mutants
and tumour escape variants, and suggest that immunisation
against likely cross-reactive variants would have to be carefully
evaluated to see if the strategy is worthwhile.
Results
Earlier analysis [21,22] using sequential alanine substitutions in
the immunogenic NP366–374 peptide established that there is some
cross-reactive, though diminished, stimulation following the
incubation of wt D
bNP366-specific CD8
+ T cells with the NP
mutant peptide containing a single asparagine to alanine
substitution at position (P) 3 (NPN3A mutant). Such cross-reactive
CD8
+ T cell responses after NPN3A stimulation are not surprising
as the partially solvent exposed P3N residue is unlikely to play any
prominent role in contacting the TCR [23]. The wt NP366–374
peptide binds to H-2D
b in an extended conformation where the
P2-Ser, P5-Asn and P9-Met are the anchor residues, P3-Asp is a
semi-anchor (partially buried/partially exposed), and P4-Glu, P6-
Met, P7-Glu and P8-Thr are solvent exposed and available for
contact by the TCR (Fig. 1). This provides the basis for a defined
experimental system that can be used to determine what happens
when a TCR repertoire is selected to what would seem (from in
vitro analysis) to be a suboptimal, cross-reactive mutant epitope.
The interpretation of in vitro analysis alone should, however, be
tempered with caution, as another mutant (M6A) that did not
cross-react at all with the wt epitope elicited a completely novel, in
vivo endogenous CTL response of equivalent magnitude when
expressed in an infectious influenza A virus [22]. What would be
the case for TCR responses elicited by influenza A viruses
expressing the mutant NPN3A peptide in the native viral protein?
Consequences of 1
o and 2
o homologous challenge for
CTL response magnitude
The NPN3A mutation was engineered into PR8 (H1N1) and
HKx31 (H3N2) influenza viruses (PR8NPN3A, HKNPN3A) to
allow cross-challenge experiments in the absence of antibody
neutralisation. The B6 mice were immunised i.p. with the virulent
PR8 mutant and wt viruses, while the HK viruses were used for
primary (1
o) i.n. infection of naı ¨ve mice or secondary (2
o) i.n.
challenge of PR8-immune (.30d previously) mice. Naı ¨ve
(primary) or PR8-immune (PR8, or PR8NPN3A) mice were
challenged i.n. with the homologous virus (HK, or HKNPN3A)
and CD8
+ T cell responses were measured using the D
bNP366 and
D
bNPN3A tetramers (Fig 2). It was immediately apparent that the
splenic D
bNPN3A
+CD8
+ set elicited by the HKNPN3A challenge
was significantly smaller on d10 (p,0.05) than the D
bNP366
+CD8
+
T cell response induced by the wt virus (Fig 2B), though there was
no significant difference between D
bNPN3A
+CD8
+ and
D
bNP366
+CD8
+ T cell numbers at the site of infection (BAL,
Fig 2A). This has been seen before [24] and suggests that the need
to clear virus from the lung results in preferential CTL localization
to the site of infection when immune T cell numbers are limited.
The profile of a diminished D
bNPN3A
+CD8
+ T cell response was
maintained into memory (d28, Fig 1C; p,0.02), supporting the
view that the relative size of persistent T cell pools reflects the
extent of antigen driven proliferation during the acute anti-viral
response.
A high proportion of the wt D
bNP366
+CD8
+ T cells in BAL
(94.0% (1
0, d10); 93.2 (2
0, d8); Fig 2A) and spleen (69.8% (1
0, d10);
93.7% (2
0, d8); Fig 2B) bound the D
bNPN3A tetramer and
produced IFN-c when stimulated by the NPN3A peptide (data not
Figure 1. A stick conformation illustrating how the influenza
NP366–374 interacts with H-2D
b. NP366–374 peptide binds to the H-
2D
b in an extended conformation. The P3-Asp, P5-Asn and P9-Met are
the anchor residues, whereas the P4-Glu, P6-Met, P7-Glu and P8-Thr are
solvent exposed and available for contact by the TCR.
doi:10.1371/journal.ppat.1001039.g001
Author Summary
Introduction of a new influenza strain into human
circulation leads to a rapid global spread of the virus
due to minimal antibody immunity. Established T-cell
immunity towards conserved viral regions provides some
protection against influenza and promotes rapid recovery.
However, influenza viruses mutate to escape the protec-
tive immunity. We found that established T cell immunity
can recognise influenza mutants with variations at
positions that are partially involved in T cell recognition.
However, an initial priming with the mutated variant
decreases recognition of the original parental virus. This
finding results from a markedly lower functional quality
and limited structural interactions of the mutant. In terms
of possible vaccination strategies for rapidly changing
viruses or tumours, it appears that priming with cross-
reactive mutants that display such characteristics would be
of no benefit as the same level of T cell immunity against
such mutants can be elicited by exposure to the original
virus.
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+ T cells elicited by
HKNPN3A infection bound the D
bNP366 tetramer and produced
IFN-c (data not shown) at levels equivalent to those seen for the
response to NPN3A, indicating a high level of cross-reactivity
between the D
bNP366
+CD8
+ and NPN3A
+CD8
+ T cell responses.
Staining with the D
bPA224 tetramer was included to establish that
the NPN3A mutation neither diminished nor enhanced other
influenza-specific CD8
+ T cell responses (Fig 2).
Despite the decreased D
bNPN3A
+CD8
+ T cell numbers
generated following primary infection (Fig 2A–C), the recall
response was substantial following HKNPN3A challenge of
PRNPN3A-immune mice (Fig 2DE) and the NP.PA immuno-
dominance hierarchy that has long been recognized for secondary
responses to wt influenza A viruses in H2
b mice [25] was
maintained (Fig 2DE). Similarly, the total cell numbers for
memory D
bPA224-specific T cells on d28 were comparable for
those primed and boosted within the wt and mutant virus
combinations (Fig 2F), while the D
bNPN3A
+ CD8
+ set was 8-fold
smaller than the wt D
bNP366
+CD8
+ population (p,0.005). Again,
the results following secondary challenge support the view that, at
least in the earlier (d28) stages of memory, T cell numbers reflect
the extent of clonal expansion during the acute phase [26]. In our
experiments, we detected D
bNP366
+CD8
+ and NPN3A
+CD8
+ T
cells by two techniques, tetramer staining and IFN-c ICS. Both
techniques gave us comparable antigen-specific CD8
+ T cell
numbers, indicating that both tetramers accurately detected
epitope-specific populations (Fig. 2GH).
Given that the NPN3A mutation was associated with a
numerically diminished response following infection with either
the wt or NPN3A influenza A viruses (Fig 2), we also asked if there
was any effect on CD8
+ T cell function or phenotype, particularly
for markers (CD62L and CD127) that discriminate between
memory T cell subsets [27,28]. More of the D
bNPN3A
+CD8
+ T
cells remained CD62L
hi when sampled at the peak of the response
Figure 2. Acute and recall CD8
+ T cell responses to D
bN3A and D
bNP366. The magnitude of CD8
+ T cell responses at the peak (d10 1
o A,B; d8
2
o D,E) or memory (d28, CF) phases following 1
o (A–C) or 2
o (D–F) infection. Cells were stained with the D
bNP366-PE, D
bNPN3A-PE or D
bPA224-PE
tetramers and anti-CD8-PerCPCy5.5 mAb. The numbers of epitope specific CD8
+ T cells were calculated from the % cells staining and the total cell
counts. The wt HK or HK-NPN3A viruses were used for 1
o i.n. infection and 2
o i.n. challenge of i.p.-primed (PR8 or PR8-NPN3A i.p. .30d previously) B6
mice. Data are mean6SD n=5 mice per group, *=p,0.01. Memory T cell numbers were also analysed on d60, and the tetramer analysis was
replicated using the ICS assay (data not shown). (G, H) Representative dot plots are shown for (G) D
bNP366 or NPN3A tetramer staining and (H)
intracellular cytokine assay after infection with either HK or HK-NPN3A for the same individual mouse.
doi:10.1371/journal.ppat.1001039.g002
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impression from the quantitative analysis (Fig 2 A–C) that there
may be less clonal expansion. On the other hand, IL-7R
expression was comparable for the D
bNPN3A
+CD8
+ and
D
bNP366
+CD8
+ T cell populations generated in virus-infected
naı ¨ve mice (Fig S1 CD) with both being (p,0.01) lower than the
values for the D
bPA224-specific set (Fig S1C). This suggests that IL-
7R levels may be antigen dose- rather than magnitude-dependent.
Neither of these differential effects was apparent for d28 memory
T cells specific for the mutant or wt epitopes (Fig S1BD).
Functional analysis of cytokine production based on short term
(5h) stimulation with cognate peptide in the ICS assay showed no
obvious differences at any stage for the D
bNP366 and D
bNPN3A-
specifc T cells, though the usual divergence [29] from the
D
bPA224
+CD8
+ T cell response was observed (p,0.01) (Fig S1 E–
H). These data suggest that NPN3A mutation leads to cross-
reactive, but diminished, CD8
+ T cell responses with comparable
cytokine production profiles.
Crystal structure and thermostability of the H2Db-NP-
N3A complex
Can the smaller response to D
bNPN3A be correlated with
structural constraints or any decrease in stability for the pMHC-I
complex? The D
bNPN3A crystal structure containing the heavy
chain of H-2D
b (residues 1–275), the b2 microglobulin (residues 1–
99) and the 9 residues of the NPN3A peptide was determined to a
2.6 A ˚ resolution (Fig. 3 and Table 1), with a final Rfactor of 22.1%
and an Rfree of 30.4%. The structure of the H-2D
b-NPN3A
complex was compared (Fig. 3B, Table 1) to the wt D
bNP366 [23].
As observed for the wt D
bNP366, the mutant NPN3A peptide
bound H-2D
b in an extended conformation, the P2-Ser, P5-Asn
and P9-Met represent the anchor residues, P3-Ala semi-anchor
residue, whereas the P4-Glu, P6-Met, P7-Glu and P8-Thr are
solvent exposed and available for contact by the TCR (Fig. 3AB).
The D
bNP366 and D
bNPN3A structures are very similar with a
root mean square deviation (r.m.s.d.) of 0.44 A ˚ on the a1–a2
domains and a r.m.s.d of 0.20 A ˚ on the peptides. With the
exception of P3-Ala, the structure of D
b-NP366 and D
b-NPN3A
superimpose well.
However, the mutation of P3-Asn to Ala leads to a loss of 35
contacts between the peptide and the MHC molecule. In
comparison to the wt NP366 that makes 636 contacts with the
H-2D
b molecule, the NPN3A peptide achieves only 601 contacts.
Interestingly, the Asn3 Ala mutation abolishes contacts between
the P3 residue of the peptide with His155 and the Tyr156 of the
MHC and eliminates one hydrogen bond between the P3-Asn
Nd2
and the P4-Glu
O (Fig. 3CD). The loss of inter-residue bonding
between 3N and 4E within the NPN3A peptide may also be
important for TCR recognition as it changes the characteristics of
the wt D
bNP366 epitope (defined as type III constraint) [30] into an
unconstrained D
bNPN3A epitope. This change of constraint
within the epitope could affect the dynamics of the peptide upon
TCR ligation, and subsequently alter TCR reactivity toward the
mutated epitope. In addition, the loss of contacts with the His155
of the MHC is of interest, as position 155, termed the ‘‘gate-keeper
residue’’ [31] is involved in contacting the TCRs in all
TCRpMHC-I complexes solved to date [32]. Thus, the lack of
interactions between the NPN3A peptide and the MHC through
His155 may also affect recognition of the complex by D
bNP366-
specific TCRs.
The loss of contacts between the peptide and the MHC
molecule could lead to decreased stability of the peptide and
subsequent changes in NPN3A presentation. To test this
hypothesis, we performed a thermostability assay on both NP366
and NPN3A bound to the H-2D
b molecule. The NP366 and
NPN3A peptides are equally effective at stabilising H-2D
b. The
pMHC-I complex with the NP366 wt peptide had a Tm of
51.860.7uC and D
bNPN3A showed a comparable level of
thermostability (Tm=51.461uC), irrespective of the concentra-
tions of the complex used for the assay. This suggests that the
NPN3A mutation does not modify the stability of the pMHC-I
complex when compared to the cognate epitope.
Naı ¨ve precursor frequency and TCR repertoire for
D
bNPN3A
Is the smaller D
bNPN3A
+CD8
+ T cell response a consequence
of diminished naı ¨ve CTL [33]? We found (Fig 4A) similar naive
CTLp counts for D
bNPN3A (34.6613.08) and D
bNP366
(28.5611.0), indicating that the smaller response to
D
bNPN3A
+CD8
+ is not due to reduced number of naı ¨ve
precursors. Furthermore, assessing the extent of Vb8.3 bias (the
dominant Vb for the D
bNP366
+CD8
+ set) within the naı ¨ve
D
bNPN3A
+CD8
+ population (Fig 4B) showed that the extent of
Vb8.3 usage (mean 13.2%64.3) (Fig. 4B) was much the same as
that determined previously [33] for naı ¨ve D
bNP366
+CD8
+ CTLps
(mean 17.1%67.4) However, sequencing the naı ¨ve
D
bNPN3A
+Vb8.3
+CD8
+ TCR CDR3b regions showed a clear
difference from the comparable wt-specific set. The ‘‘public TCR’’
dominance characteristic of D
bNP366
+Vb8.3
+CD8
+ T cells in both
pre-immune [33] and immune [34] TCRb repertoires [34] was
not a prominent feature of the D
bNPN3A-specific TCR
repertoire. These public TCRs were found in only one
(SGGANTGQL and SGGGNTGQL) or two (SGGSNTGQL)
of the 10 mice tested (Fig. 4C). Thus, although the naı ¨ve CTLp
frequencies are comparable for D
bNP366
+Vb8.3
+CD8
+ and
D
bNPN3A
+Vb8.3
+CD8
+ T cells and there is some overlap of
some cross-reactive TCRs, the two repertoires are far from
identical. The roughly equivalent numbers of precursors specific
for the wt D
bNP366 and mutant NPN3A peptides were unexpected
considering the lower response after infection with the mutated
virus. The lower magnitude of the NPN3A
+CD8
+ T cell response
and narrower TCRb repertoire suggest that only a proportion of
naı ¨ve NPN3A
+CD8
+ precursors are being recruited into the
immune response or that, once recruited, these cells do not expand
efficiently. Inefficient recruitment and/or expansion early after
influenza infection, despite large naı ¨ve CTL precursor numbers,
have been recently documented by our group as key determinants
of subdominance for D
bPB1-F262 and K
bNS2114-specific respons-
es [33].
D
bNPN3A selects distinct and more restricted TCR Vb
signatures
The next step was to dissect the immune D
bNPN3A
+CD8
+
CTL repertoire to determine how TCR diversity relates to the size
of the immune D
bNPN3A
+CD8
+ T cell response. The D
bNPN3A-
specific CD8
+ T cells were first analysed for Vb usage by staining
with a panel of anti-TCRVb mAbs and the D
bNPN3A tetramer.
After infection with the NPN3A viruses, the strong Vb8.3 bias
characteristic of responding D
bNP366
+CD8
+ T cells [34,35] was
prominent for the D
bNPN3A
+CD8
+ sets in only 50% of the
immune mice (n=10). The mutant D
bNPN3A
+CD8
+ T cells
utilized a variable spectrum of TCRVb elements, with over-
representation of Vb 7, 8.1/8.2, 9, 11, and 12 after primary (Fig
S2A) or Vb6, 7 and 9 following secondary (Fig S2B) NPN3A virus
challenge.
We analysed TCRb clonotypes within the Vb8.3 as (i) it is still a
preferred region (29.8%620.2) of NPN3A
+CD8
+ T cell response)
Cross-Reactivity and T Cell Efficacy
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cross-reactive CD8
+ T cell responses between NP366 and NPN3A
as they are prominent in both populations. Overall, the mutant
and the wt immune Vb8.3 repertoires appear different. Single-cell
RT-PCR and sequencing of the CDR3b region of tetra-
mer
+Vb8.3
+CD8
+ T cells following either HK or HK-NPN3A
infections showed that (Table S1) the mutant D
bNPN3A
+CD8
+ T
cells utilized different Jb regions (primary (1
0): Jb1.1, Jb1.3;
secondary (2
0): Jb1.1, Jb1.6, Jb2.2) in comparison to the wt
D
bNP366
+CD8
+ population (1
0:J b2.2, Jb2.4; 2
0:J b 2.2), and
showed evidence of more variable CDR3b loop lengths (8–9 aa).
The reduction (relative to the wt D
bNP366)i nV b8.3 usage by the
D
bNPN3A
+CD8
+ T cells reproduces the relative loss of ‘‘public’’
wt TCRs found for the naı ¨ve repertoire (Fig 4B). This likely
reflects that the N3A mutation has disrupted an ‘‘optimal’’ TCR/
pMHC fit that maximizes antigen-driven clonal expansion.
Indeed, the public TCRs were not a prominent feature of the
D
bNPN3A
+CD8
+ set, being found in only 4 of the 7 NPN3A-
infected mice at a very low frequency, namely 0% in the 1
0
response and 22.9% in the 2
0 response (Table 2). This is in
contrast to the D
bNP366
+CD8
+ Vb8.3
+ TCR repertoire [34] that
is largely (90%) comprised of high-frequency, public clonotypes
found in all infected B6 mice [34].
These results also establish that the naı ¨ve D
bNPN3A
+ CD8
+
TCR repertoire (Fig. 4C) is predictive of the immune
D
bNPN3A
+ CD8
+ TCRb response (Table 2). The relative lack
of a ‘‘public’’ response translated to a profile of reduced
‘‘sharing’’ between individual mice, and a total increase in the
number of D
bNPN3A
+CD8
+ clonotypes due to the ‘private’
nature of TCRb repertoire for each mouse (Table 2). Even so,
the clonotypic diversity within individual NPN3A virus-infected
mice was reduced compared to the spectrum found following wt
virus-infection. This was true whether the cells were sorted using
the wt D
bNP366 or the mutant D
bNPN3A tetramer, reflecting
the significant cross-reactivity between the D
bNP366 and
D
bNPN3A-specific populations recovered from mice infected
with the NPN3A viruses. By the measure of tetramer binding, it
thus seems that the NPN3A virus is selecting a less diverse
repertoire than the wt virus, with the repertoire being almost
completely cross-reactive with that elicited by the wt D
bNP366
epitope.
Similarly, when the D
bNP366
+Vb8.3
+CD8
+ T cells induced by
wt HK infection were sequenced, the majority of the TCRb
clonotypes were detected with both the D
bNP366 and D
bNPN3A
tetramers (Table 3). However, a switch in frequency was seen for
some CDR3b-defined clonotypes, indicating selective binding of
particular TCRs by the D
bNPN3A tetramer. For example in M9
and M10 (Table 3) the ‘public’ SGGANTGQL CDR3b-sequence
dominated the D
bNP366
+Vb8.3
+CD8
+ T cell population, whereas
this sequence was less commonly detected in the same mice by the
D
bNPN3A tetramer. The difference could, of course, reflect
diversity in TCRa usage.
Figure 3. Structure of the D
bNP366–374 and D
bNPN3A complexes. The H2D
b molecule is in a cartoon representation with the a1-helix on the
back and the a2-helix removed for better clarity. The peptide is represented in stick conformation with the C terminus on the right. (A) The NPN3A is
in purple and (B) the NP366 in blue, with the p3 mutation in yellow. (B) Overlay of the peptide-binding cleft for H2D
bNP366 and H2D
bNPN3A with the
a1-helix on top and the a2-helix on the bottom. (C) Contacts with the H-2D
b molecule by (C) P3N in NP366 and (D) P3A in NPN3A. The Asn3 mutation
to alanine abolishes contacts between the P3 residue of the peptide with His155 and the Tyr156 of the H-2D
b.
doi:10.1371/journal.ppat.1001039.g003
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bNP366 and D
bNPN3A
tetramers, sequencing of the secondary TCRb repertoire (M11–
M13) induced by challenge with the homologous (PR8, then HK)
viruses showed less divergence within the wt D
bNP366
+CD8
+ T
cell specific population. Interestingly, clonotypes like KGGS-
NTGQL were enriched by the D
bNPN3A tetramer in some but
not other mice (Table 3; present in M9 but not M12) suggesting,
again, the likely importance of Vb-Va chain pairing for
recognition of the native D
bNP366
+CD8
+ T cells with the mutant
D
bNPN3A tetramer. Thus, the analysis suggests that only a subset
of the repertoire generated by wt infection is able to recognize the
D
bNPN3A epitope, though this population is more diverse than
that generated in response to the mutant NPN3A virus. All the
statistical differences (Table 2, Table 3) were confirmed when the
data were standardized to a number of sequences (data not
shown).
We further analyzed the D
bNPN3A
+Vb9
+CD8
+ set that was
prominent in 2 of the HK-NPN3A secondarily challenged mice.
An average of 1.561 TCRb clonotypes was found within this
population (Table S2). Again, the D
bNPN3A
+Vb9
+CD8
+ TCRb
repertoire emerged as essentially restricted and private. However,
TCRb analysis within other Vbs for NPN3A
+CD8
+ T cells would
need to be performed to compare the whole TCR repertoires.
Analysis of Va chain usage for the mutant D
bNPN3A
+CD8
+
and wt D
bNP366
+CD8
+ T cells by PCR with a panel of Va specific
primers established that those two T cell responses indeed tend to
utilise different Va chains. The wt D
bNP366
+CD8
+ T cell
population [36] (Day EB, unpublished) tended to use Va8 and
Va17.3 (n=3). Conversely, the D
bNPN3A
+CD8
+ TCRs prefer-
entially expressed Va4, Va5 and Va11 (Table S1). While the
sample size is small and there are at least 72 different Va chains,
these results provide a snapshot of the mutant D
bNPN3A
+ and wt
D
bNP366
+ populations and suggest that there are differences in
both Vb and Va TCR chain usage.
Response characteristics following heterologous
challenge and TCR/pMHC-I avidity
As there was substantial cross-reactivity in vitro (Fig. 2) for the
D
bNP366 and D
bNPN3A-specific responses, it was important to
determine whether memory T cells that cross-react for the
D
bNP366 and D
bNPN3A epitopes are preferentially recalled by
secondary infection with the heterologous virus. Mice that were
primed with the PR8NPN3A and then challenged with either the
wt HK or mutant HKNPN3A viruses showed equivalent recall of
D
bNPN3A
+CD8
+ T cells during the acute phase of the secondary
response. This was detected by IFN-c production (Fig 5A) and
tetramer staining (data not shown) and is consistent with the TCR
CDR3b analysis (Table 2). Conversely, when mice were firstly
primed with wt PR8, then later infected i.n. with either the wt HK
or mutant HK-NPN3A, the D
bNP366
+CD8
+ T cells were
differentially recalled indicating that (in the absence of primary
selection from the naı ¨ve repertoire by the mutant epitope) only
some of the D
bNP366
+CD8
+ memory T cells that were expanded
by heterologous challenge bind D
bNPN3A (Fig. 5A). Interestingly,
wt priming and challenge (1
0 PR8-.2
0 X31) resulted in
significantly higher CD8
+ T cells numbers (Fig. 5B) than were
found for any secondary CD8
+ T cell responses after NPN3A
priming (1
0 PR8-NPN3A-.2
0 X31-NPN3A and 1
0 PR8-NPN3A-
.2
0 X31). These results lead to two main conclusions: (i) priming
with the wt virus elicits CD8
+ T cells that respond relatively well to
a subsequent infection with cross-reactive variant (ie 1
0 PR8-.2
0
X31-NPN3A=1
0 PR8-NPN3A-.2
0 X31-NPN3A); (ii) priming
with the cross-reactive variant can be detrimental as the
diminished primary response may limit the full expansion of
CD8
+ T cells that are able to respond to the subsequent wt
infection (ie 1
0 PR8-NPN3A-.2
0 X31 is lower than 1
0 PR8-.2
0
X31) and skew the TCR usage. Thus, using NPN3A for either
priming or the challenge gives an equally poor response.
To determine whether such decreased CD8
+ responses elicited
after heterologous challenge would affect influenza virus clearance,
we performed experiments to examine the protective efficacy of
cross-reactive CD8
+ T cell repertoires. We performed prime-and-
challenge studies in mMT mice lacking B cells to ensure that
antibody responses did not mask any possible inhibitory effects of
‘‘suboptimal’’ TCRs on viral clearance. As suggested by CD8
+ T
cell data, assessment of lung viral titres showed delayed viral
clearance on d6 after the secondary infection in case of
heterologous prime-and-boost (PR8-.X31-NPN3A and PR8-
NPN3A-.X31) compared to homologous infections (PR8-.X31
or PR8-NPN3A-.X31-NPN3A) (Fig. 5B). These results indicate
that recall of ‘‘suboptimal’’ TCRs for a single T cell specificity can
lead to delayed viral clearance, despite the presence of other
influenza CD8
+ T cell responses (D
bPA224
+CD8
+,D
bPB162
+CD8
+,
K
bNS1114
+CD8
+,K
bPB1703
+CD8
+).
Table 1. Data collection and refinement statistics.
Data Collection Statistics H2D
b-NPN3A
Temperature 100K
Space group I222
Cell Dimensions (a,b,c) (A ˚) 93.64, 94.98, 132.24
Resolution (A ˚) 50.00 - 2.60 (2.70-2.60)
Total number of observations 131799 (13218)
Number of unique observations 18241 (1905)
Multiplicity 7.2 (6.9)
Data completeness (%) 98.6 (97.7)
I/sI 27.55 (6.37)
Rmerge
a (%) 6 (30.3)
Refinement Statistics
Non-hydrogen atoms
Protein 3040
Water 46
Resolution (A ˚) 2.60
Rfactor
b (%) 22.1
Rfree
b (%) 30.4
Rms deviations from ideality
Bond lengths (A ˚) 0.012
Bond angles (u) 1.468
Ramachandran plot (%)
Most Favoured Region 85.5
Allowed Region 12.5
Generously allowed region 1.7
B-factors (A ˚2)
Average main chain 40.806
Average side chain 40.807
aRmerge=S|Ihkl2,Ihkl.|/SIhkl.
bRfactor=Shkl|| F o|2|Fc|| / Shkl|Fo| for all data except <5% which were used for
Rfree calculation. Values in parentheses are for the bin of highest resolution
(approximate interval=0.5 A ˚).
doi:10.1371/journal.ppat.1001039.t001
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following in vivo virus challenge were reflected in the results found
for in vitro measurements of ‘‘functional avidity’’ (Fig 6). Pulsing
immune spleen cells recovered directly ex vivo with graded doses of
wt or mutant peptide in the ICS assay showed comparable levels of
IFN-c induction (Fig 6AC) in every situation but one, the exposure
Figure 4. TCR repertoire of naı ¨ve D
bNPN3A
+CD8
+ T cells. Effects of the N3A substitution within NP366–374 on (A) naı ¨ve T cell precursor
frequency, (B) Vb8.3 bias and (C) naı ¨ve TCRb repertoire within the D
bNPN3A
+Vb8.3
+CD8
+ set. (A) Naı ¨ve D
bNPN3A
+ and D
bNP366
+CD8
+ T cell precursors
within lymph nodes and spleens were identified with the D
bNPN3A-PE and D
bNP366-PE tetramers using an established tetramer enrichment protocol
[53]. (B) Naı ¨ve D
bNPN3A
+CD8
+ T cells were assessed for the conservancy of Vb8.3 bias. (C) a CDR3b sequences within the naı ¨ve D
bNPN3A
+Vb8.3
+CD8
+
T cells were determined by a single-cell PCR, amplification of Vb8.3 transcripts and sequencing.
doi:10.1371/journal.ppat.1001039.g004
Table 2. Frequency of TCRb clonotypes in D
bNPN3A
+ Vb8.3
+CD8
+ T cells after 1
0 (M1, M2) and 2
0 (M3 to M7) mutant HK-NPN3A
infection detected with either the D
bNP366
+ or D
bNPN3A
+ tetramer.
HK-NPN3A infection 1
0 response 2
0 response
M1 M2 M3 M4 M5 M6 M7
CDR3b Jb aa NP N3A NP N3A NP N3A NP N3A NP N3A NP N3A NP N3A
SGGANTGQL 2S2 9 3 9 2 5
SGGSNTGQL 2S2 9 11 1 2 3
SGGGSTGQF 2S2 9 11
SGGGNTGQL 2S2 9 12 1.5 99 3
SGGGNNGHL 2S2 9 2
KGGGNTGQL 2S2 9 100 80
SDAASTEV 1S1 8 84 88
SDAANTEV 1S1 8 16 12 19 11
SDAVATEV 1S1 8 62 82
SDASSTEV 1S1 8 98 92
SDSANTEV 1S1 8 3 4.5
RRDRGGNTL 1S3 9 95 100
SGGTENSPL 1S6 9 95
SDAQLYAEQ 2S1 9 2
SVGGRAEQ 2S1 8 1.5
SDWGSQNTL 2S4 9 87 100
SDGGGTYEQ 2S5 9 2
TOTAL sequences 44 42 32 43 64 32 34 66 59 35 72 61 50 61
M: individual mouse; NP: D
bNP366 tetramer; N3A: D
bNPN3A tetramer.
1
0 responses were generated by i.n. HK-NPN3A infection of mice; 2
0 responses were generated by priming mice with i.p. PR8-NPN3A virus then challenging with i.n. HK-
NPN3A virus; D
bNP366: complex of H2D
b and NP366–374 peptide; D
bNPN3A: complex of H2D
b and NPN3A366–374 peptide.
doi:10.1371/journal.ppat.1001039.t002
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the immune repertoire selected by D
bNP3A shows evidence of
equivalent avidity following stimulation with the NPN3A or NP366
peptides, D
bNP366 induces a response that is of higher avidity for
the wt than the mutant epitope. The same effect was seen even
more clearly when three (all expressing the SGGGNTGQL
CDR3b) T cell hybridoma lines [37] specific for D
bNP366 were
stimulated with the two peptides (Fig 6DE). This result is in accord
with findings from both the TCR repertoire analysis of cross-
reactive clonotypes, assessed by tetramer binding (Table 2), and
the response magnitudes determined following homologous and
heterologous virus challenge (Fig 5). Thus, priming and recall of
cross-reactive CD8
+ T cells recognising mutant viral epitopes
reflects functional (defined as responsiveness to a peptide) pMHC-
TCR avidity.
To determine the pMHC-I avidity of the responding
D
bNP366
+CD8
+ and NPN3A
+CD8
+ T cells, we additionally
performed tetramer dilution (Fig. 7A–C) and tetramer dissociation
(Fig. 7D–E) assays. While tetramer dissociation assay measured the
‘‘off-rate’’ component of pMHC-I avidity, tetramer dilution
technique assessed the overall pMHC-I avidity (both the ‘‘on’’
and ‘‘off’’ rates). Furthermore, we also assessed CD8b-dependence
for functional activation (a measure of low avidity CD8
+ T cells) of
both wt D
bNP366
+CD8
+ and the mutant NPN3A
+CD8
+ T cells by
anti-CD8b mAb blocking, followed by IFN-c ICS (Fig. 7G–I). Our
data obtained from those three additional measures of pMHC-I
avidity confirmed the results obtained by the peptide titration
combined with ICS (functional avidity, Fig. 6) and further
suggested significantly lower pMHC-I avidity of the wt
D
bNP366
+CD8
+ (generated by the wt HK infection) for NPN3A
variant.
Discussion
The P3N within the immunodominant influenza virus-specific
D
bNP366 epitope is a partially solvent exposed, and non-prominent
for TCR binding, residue that is predominantly buried within the
MHC cleft [21,23]. The NPN3A mutation leads to both decreased
recruitment of CD8
+ T cells and a narrowed clonotype selection
profile within Vb8.3 and Vb9 regions. Structurally, the mutation
leads to a loss of a number of contacts between the NPN3A
peptide and the MHC-I molecule, including a contact with the
gate-keeper residue at position 155, and unaltered stability of the
H-2D
b-NPN3A complex. The fact that the NPN3A mutation
affects contacts with the MHC-I at His155, known to play an
important role in TCR-pMHC structures in general, is likely to
indirectly compromise the TCR recognition. By loosing the bond
with the Asn3, His155 may gain more flexibility and thus be
inappropriately placed for the subsequent TCR ligation onto the
NPN3A peptide. Alternatively, it is also possible that a small part
of the solvent-exposed head group of the Asn3 residue in the wt
NP366 peptide might, to some extent, be directly interacting with
the TCR following ligation.
Table 3. Frequency of TCRb clonotypes in D
bNP366
+Vb8.3
+CD8
+ T cells after 1
0 (M8–M10) and 2
0 (M11–M13) wt influenza virus
infection detected with either the D
bNP366
+ or D
bNPN3A
+ tetramer.
HK infection 1
0 response 2
0 response
M8 M9 M10 M11 M12 M13
CDR3b Jb aa NP N3A NP N3A NP N3A NP N3A NP N3A NP N3A
SGGANTGQL 2S2 9 67 70 53 3 63 22 10 15 36 48 24 22
SGGSNTGQL 2S2 9 22 16 2 17 27 50 13 2 50 16
SGGGNTGQL 2S2 9 11 7 5
SGGGSTGQL 2S2 9 17 7
RGGSNTGQL 2S2 9 2 4
RGGANTGQL 2S2 9 5 13 15 36 6 11
RGGGNTGQL 2S2 9 4
RGGAPTGQL 2S2 9 10
KGGSNTGQL 2S2 9 63 3 38 2
KGGGNTGQL 2S2 9 25 60 4 4 3
SGGQGNSPL 2S2 9 2
KAGGSTGQL 2S2 9 48
KAGGGTGQL 2S2 9 5
RALGRNTEV 1S1 9 2 3
SDAGKTEV 1S1 8 63 0
RDSANTEV 1S1 8 21 5 8
SDAGAEQ 2S1 7 2 5
SDWGWQNTL 2S4 9 40 27
TOTAL sequences 27 43 45 30 30 60 40 47 47 44 34 37
M: individual mouse; NP: D
bNP366 tetramer; N3A: D
bNPN3A tetramer;
1
0 responses were generated by i.n. HK infection of mice; 2
0 responses were generated by priming mice with i.p. PR8 viruses then challenging i.n. with the HK virus;
D
bNP366: complex of H2D
b and NP366–374 peptide; D
bNPN3A: complex of H2D
b and NPN3A366–374 peptide.
*Predominant: $15%,
#Common: present in all mice sampled.
doi:10.1371/journal.ppat.1001039.t003
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NPN3A peptide and H-2D
b, the stability of the peptide-MHC-I
complex remains constant for both NP366 and NPN3A. This
suggests that the Asn3 as a secondary anchor does not play an
important role in stabilizing the peptide within the MHC-I. The
structural basis for the diminished recruitment of D
bNPN3A-
specific CD8
+ T cells is thus likely to rest in the way that the
partially-solvent exposed residue contacts MHC-I and modifies
TCR ligation.
The emerging D
bNPN3A
+CD8
+ T cell population was
characterised by different Va and Vb preference, distinct CDR3b
sequences and a lower overall TCR diversity in comparison to wt
D
bNP366
+CD8
+ T cells. These findings suggest that a very limited
spectrum of CD8
+ T cells can recognise the D
bNPN3A mutant
structure. Interestingly, a similar P3 substitution in the influenza
virus D
bPA224 epitope had no affect on D
bPA224
+CD8
+ Tc e l l
recognition and recruited a diverse array of TCR clones
comparable to the spectrum found for the wt response [21].
This suggests that the partially-exposed P3 residue plays a greater
structural and/or TCR recognition role for the ‘‘featureless’’
D
bNP366 than for the ‘‘featured’’ D
bPA224 complex reflecting, in
turn, the more limited spectrum of TCRs that bind D
bNP366
[21]. Taken together, it appears that partially-exposed residues
within viral peptides can provide important contacts with the
MHC-I, which can in turn cause remote effects that modify
antigenicity for the TCR-pMHC-I complex and impact on both
TCR repertoire selection and the magnitude of CD8
+ Tc e l l
responses.
Interestingly, there were no differences in function or
phenotype characteristics for the D
bNP366
+CD8
+ and
NPN3A
+CD8
+ T cells, although those two CTL sets had a high
proportion of different TCR clones. This is in accordance with
previous studies showing that the simultaneous production of
antiviral cytokines [29] and IL-7R [20] expression is antigen
dose- rather than magnitude-related. Conversely, levels of the
CD62L [38,39,40] activation marker differed for the
D
bNP366
+CD8
+ and NPN3A
+CD8
+ populations, indicating that
response magnitude has some relationship to the activation status
Figure 5. Heterologous 2
o challenge with the wt HK and mutant HK-NPN3A viruses. Naı ¨ve (A) B6 or (B) mMT mice were primed i.p with the
mutant PR8-NPN3A and challenged i.n. 6 weeks later with 1610
4 p.f.u. of either the wt HK or the mutant HK-NPN3A virus. Alternatively, naı ¨ve mice
were primed i.p. with the wt PR8 virus and challenged i.n. 6 weeks later with 1610
4 p.f.u. of the wt HK or the mutant HK-NPN3A virus. (A) The
magnitude of the CD8
+ T cell response measured 8d after 2
0 infection was determined by the ICS assay for IFN-c. Data represent mean6SD (n=5) (B)
Viral clearance after the secondary homologous (PR8-.X31 and PR8-NP-N3A.X31-NPN3A) or heterologous (PR8-.X31-NPN3A and PR8-NP-
N3A.X31) challenge. Lungs were sampled at days 5 and 6 after secondary infection and homogenized for virus titration by plaque assay on MDCK
cell monolayers. Data represent the mean and n=3–5 mice per group. *=p,0.01 #=p,0.05.
doi:10.1371/journal.ppat.1001039.g005
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+ T cells [40,41,42] which may, perhaps, reflect the extent
of CTL proliferation.
The TCR repertoires specific for D
bNP366 and D
bNPN3A
appear to be quite distinct. The response overall for wt
D
bNP366
+CD8
+ T cells is characterised by conserved, ‘‘public’’
clonotypes that constitute the majority (83.5% in 1
0 response and
92.3% in 2
0 response) of the selected TCR repertoire [34]. These
public clonotypes are not a prominent feature of the
D
bNPN3A
+CD8
+ set, being found only in 4/7 NPN3A-infected
mice at very low frequency. Since we know that these TCR
clonotypes are present in all B6 mice [34], the difference
presumably reflects the lower TCR avidity for D
bNPN3A, as
indicated by the T cell hybridoma analysis where they were shown
to require 1000 times more NPN3A than NP366 peptide for
optimal stimulation. Since the public clonotypes cannot be
efficiently recruited into the immune response by the mutated
N3A virus, this could have created a ‘‘hole’’ in TCRs capable of
recognising the mutated epitope, which subsequently can lead to a
reduction in T cell immunogenicity [43]. However, though both
the D
bNP366
+CD8
+ and D
bNPN3A
+CD8
+ T cell responses are
characterised by quite distinct TCR repertoires, the majority are
bound by both the D
bNP366 and D
bNPN3A tetramers and can be
detected by stimulation with either the NP366 or the NPN3A
peptides, suggesting that a clonal dissection of TCR clonotypes is
needed to make a valid interpretation about the truly cross-
reactive CD8
+ T cell responses. These findings also raise questions
concerning the true correlation between pHMC-I tetramer
binding in vitro and the in vivo selection of a responding TCR
repertoire.
Overall, the results indicate that a loss of a number of contacts
between the NPN3A peptide and the MHC-I molecule and lower
functional and structural pMHC-I avidity (for wt D
bNP366)
D
bNPN3A selects a narrowed TCR repertoire of ‘‘best fit’’ TCRs
from a spectrum of naı ¨ve clonotypes that, once activated, clonally
expanded and engaged in an immune response, have sufficient
avidity to be recalled by exposure to the wt D
bNP366 epitope.
Conversely, the ‘‘better’’ fit D
bNP366 finds a sufficient spectrum of
high avidity TCRs within that available naive repertoire and does
not (likely because of clonal competition) select most of the TCR
ab pairs that interact optimally with D
bNPN3A. Priming with the
wt virus thus establishes memory for only a very limited secondary
response to the mutant. Similar to our results, subtle variations
within the anchor residue of H
b peptide/I-E
k also decreased
peptide-MHC class II affinity and the activation of responding T
cells [44].
Thinking about this in terms of possible vaccination strategies
for use against rapidly changing viruses or tumor epitopes, it
appears that priming with cross-reactive mutants that have
characteristics comparable to NPN3A would be of no benefit (or
even could be detrimental as evidenced by delayed viral
clearance) as the same level of T cell immunity against such
mutants can be elicited by exposure to the wt epitope. On the
other hand, changes like the non-cross-reactive NP-M6A
mutation [22] that induce a completely novel, high quality
response might merit incorporation in an experimental vaccine or
immunotherapy strategy. Overall, working out the topographical
constraints that determine these differential response profiles
would seem eminently worthwhile.
A further reason for defining the structural rules governing
TCR cross-recognition is that similar effects have been found for
different epitopes derived from unrelated viruses. Published studies
provide evidence for cross-reactive CD8
+ T cell responses between
influenza A virus and Epstein-Barr virus (EBV) [45], influenza A
virus and Hepatitis C virus (HCV) [46,47] or lymphocytic
choriomeningitis virus (LCMV) and Pichinde virus (PV) [48].
Such heterologous cross-reactive immunity can unintentionally
skew TCR recruitment, result in a narrow TCR repertoire and
subsequent viral escape [48] as well as influenza disease severity
Figure 6. Decreased TCR functional avidity of D
bNPN3A-primed T cells for D
bNP366. (A–C) Responsiveness of CD8
+ T cells to varying
peptide concentrations was determined as a measure of functional TCR avidity for the cognate pMHCI complex. (A,B) D
bNP366
+ CD8
+ and (A,C)
D
bNPN3A CD8
+ T cells recovered from mice 2
o-challenged with wt or NPN3A viruses were assessed for functional TCR avidity using the ICS assay. The
enriched splenocytes analysed by IFN-c ICS were stimulated in vitro with 4-fold dilutions of the NP366, or NPN3A peptide. Data represent mean6SD
(n=4), *=p,0.01. (D,E) The response profiles of monoclonal D
bNP366-specific LacZ-inducible (22) T cell hybridomas (3 distinct lines all with the
‘‘public’’ SGGGNTGQL CDR3b sequence) to peptide-pulsed H-2D
b splenocytes presenting the (D) wt D
bNP366 or (E) D
bNPN3A epitopes were assessed
in LacZ assay [22].
doi:10.1371/journal.ppat.1001039.g006
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+ T cell responses
clearly merits more attention.
Materials and Methods
Ethics statement
All animal experimentation was conducted following the
Australian National Health and Medical Research Council Code
of Practice for the Care and Use of Animals for Scientific Purposes
guidelines for housing and care of laboratory animals and
performed in accordance with Institutional regulations after
pertinent review and approval by the University of Melbourne
Animal Ethics Experimentation Committee in Melbourne.
Mice and viral infection
C57BL/6J (B6, H2
b) and mMT mice were bred and housed
under specific pathogen free conditions at the Department of
Microbiology and Immunology, University of Melbourne. For the
generation of acute influenza responses mice were lightly
anaesthetised by inhalation of methoxyflurane and infected
intranasally (i.n.) with 1610
4 plaque forming units (p.f.u.) of
HK-X31 (H3N2, X31) or modified HK-X31 (HK-NPN3A)
influenza A viruses in 30ml of PBS. For recall responses mice
were first primed intraperitoneally (i.p.) with 1.5610
7 p.f.u. of the
serologically distinct PR8 (H1N1) or modified PR8 (PR8-NPN3A)
influenza A viruses, in 500ml of PBS. Viruses share the same
internal components for NP and PA from which CD8 epitopes are
derived [49]. Virus stocks were grown in the allantoic cavity of 10
day old embryonated chicken eggs, from which the viral titre was
determined by plaque assay on monolayers of Madin derby canine
kidney (MDCK) cells.
Generation and titration of recombinant influenza viruses
Recombinant influenza viruses with the single amino acid
substitution (N3A) within the NP366 peptide, ASNENMETM,
were generated using the eight-plasmid reverse genetics system
[50]. The substitution was first incorporated by site directed
mutagenesis using PCR primers encoding N3A366 peptide,
ASAENMETM, and the opposite primer encoding NP. Recom-
binant PCR products encoding N3A366 were digested with BsmB1
and ligated into the alkaline phosphatase treated pHW2000
vector. Recombinant viruses (HK-NPN3A and PR8-NPN3A)
were rescued following transfection of MDCK-293T cell co-
culture with the eight plasmids encoding influenza segments.
Viruses were then amplified in the allantoic cavity of 10-day old
embryonated chicken eggs, and the viral titre determined by
plaque assay of allantoic fluid infecting monolayers of MDCK
cells. There was any evidence of altered fitness in vivo for the
Figure 7. Decreased pMHC avidity and CD8b-independence for functional avidity of D
bNPN3A-primed T cells for D
bNP366. pMHC-
TCR avidity was assessed by three measures: (A–C) the overall pMHC avidity (tetramer ‘‘on’’ and ‘‘off’’ rates) by tetramer dilution, (D–F) tetramer ‘‘off’’-
rate by tetramer dissociation and (G–I) CD8b-dependence by anti-CD8b blocking combined with ICS. Splenocytes were obtained from mice 2
o-
challenged with wt or NPN3A viruses. (A–C) D
bNP366
+ CD8
+ and D
bNPN3A CD8
+ T cells were stained with 2-fold dilutions of PE-conjugated tetramers,
followed by anti-CD8 staining. (D–F) Cells were stained with either the D
bNP336 or D
bNPN3A tetramers at the saturating concentration, then
incubated at 37
oC with a mAb to H2D
b to prevent rebinding of dissociated tetramer. The progressive diminution in tetramer staining was measured
by flow cytometric analysis. (G–I) Lymphocytes were pre-cultured in the presence or absence of anti-CD8b antibody (53.5-8) (10 mg/ml). Cells were
then stimulated for 5 h with peptide, IL-2 and GolgiStop also in the presence or absence of anti-CD8b antibody (5 mg/ml). Following stimulation, cells
were analysed for CD8 and IFNc expression. Shown is (G) the percentage of CD8
+ T cells producing IFN-c in the presence or absence of anti-CD8b
blocking mAb, (H) mean fluorescence intensity (MFI) of IFN-c staining, (I) the percentage of CD8
+ cells dependent on anti-CD8b for IFN-c production.
Tetramer staining was performed in the presence of NaAz, then washed and incubated with anti-CD8 mAb. The progressive diminution in tetramer
staining was measured. The Td50 value defining the time to 50% tetramer loss. Data represent mean6SD (n=4–5 mice per group), *p,0.01;
#p,0.05.
doi:10.1371/journal.ppat.1001039.g007
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following i.n. challenge of naı ¨ve B6 mice were found to be
equivalent for the wt HK and mutant viruses (Fig S3A). Similarly,
the levels of CTL activity found using target cells infected with
HKNPN3A or the HK wt viruses were comparable, and the same
was seen for peptide pulsed cells, suggesting that antigen
presentation of NPN3A peptide remains constant (Fig S3 BC).
Determination of viral titres
Lungs taken from mice after primary viral infection (Fig. S3A)
or prime-and-boost approach using homologous (PR8-.X31 and
PR8-NPN3A-.X31-NPN3A) or heterologous (PR8-.X31-
NPN3A and PR8-NPN3A-.X31) strategy (Fig. 5B) were
homogenised and the virus-containing supernatant above the cell
debris was harvested and stored at 270uC. Titres of infectious
virus in the lung supernatants were determined by plaque assay on
monolayers of MDCK cells.
Tissue sampling and cell preparation
Spleen and bronchoalveolar lavage (BAL) samples were
recovered from mice at acute phases of the primary and secondary
infections (d10 and d8 respectively), and the BAL samples were
incubated on plastic petri-dishes for 1hr at 37
0C to remove
macrophages. The spleens were disrupted and enriched for CD8
+
T cells using goat anti-mouse IgG and IgM antibodies (Jackson
ImmunoResearch Labs, West Grove, PA, USA). For assessment of
naı ¨ve precursor frequency of N3A366
+CD8
+ T cells, spleens and
lymph nodes (inguinal, brachial, axillary, superficial cervical, and
mesenteric) were collected from naı ¨ve mice and processed to
single-cell suspensions.
Tetramer and phenotypic staining of CD8
+ T cells
Lymphocytes from the BAL and spleen were stained with
tetramers conjugated to Strepavidin-APC or PE (Molecular
Probes, Eugene, OR, USA) at optimal staining concentrations
(10 mg/ml D
bNP366,4 0mg/ml D
bN3A366, and 10 mg/ml D
bPA224
tetramers) for 1hr at room temperature. Cells were washed twice
in FACS buffer, and stained with 1 mg/ml CD8-PerCP Cy5.5,
5 mg/ml CD62L-FITC and 5 mg/ml CD127-APC mAbs (BD
Biosciences) for 30 mins on ice, washed twice and analysed by flow
cytometry on the FACS Calibur (BD Immunocytometry) and
analysed by CellQuest Pro software (BD Immunocytometry). We
titrated all the batches of all the tetramers used in this study. We
used tetramers at optimal concentrations (10–40mg/ml) based on
both the percentage of epitope-specific CD8
+ T cells and the mean
fluorescence intensity (MFI) of tetramer staining. A Scatchard
analysis [51] based on the tetramer dilution assay (Fig. 7 A–C) was
also plotted (Fig. S4) and confirmed our observations from routine
tetramer titrations that the D
bNP366 tetramer displays slightly
superior pMHC binding capacities over the NPN3A tetramer at a
concentration ,5mg/ml.
Tetramer dilution and tetramer dissociation analyses
CD8
+ T cells from spleen were stained with the D
bNP366 and
D
b-NPN3A tetramers conjugated to Streptavidin-PE (Molecular
Probes, Eugene, OR) for 60mins at room temperature. For a
tetramer dilution assay, 2-fold dilutions of PE-conjugated
tetramers were used at a range of concentrations (0.15–40mg/
ml). For a tetramer dissociation assay, lymphocytes were stained at
the optimal concentration of PE-conjugated tetramers as assessed
by tetramer titration as determined by both the percentage of
tetramer
+CD8
+ T cells and mean fluorescence intensity (MFI).
Cells were washed twice in FACS buffer (10%BSA/0.02% NaAz
in PBS), stained with a FITC-conjugated mAb to CD8a (BD
Biosciences Pharmingen) for 30mins on ice, washed and analysed
by flow cytometry. As a measure of pMHC avidity, splenic T cells
were used in tetramer dissociation assay [29]. After staining with
tetramer, T cells were washed and incubated in the presence of
anti-H2D
b antibody at 5mg/ml at 37
0C to prevent tetramer
rebinding. Cells were removed at intervals, stained with the FITC-
conjugated mAb to CD8a and analysed by flow cytometry. Loss of
tetramer
+CD8
+ T cells at particular time-points was calculated in
comparison to tetramer staining at t=0mins.
Peptide stimulation and intracellular cytokine staining
Enriched T cell populations from spleen and BAL were
stimulated with one of the NP366, N3A366,P A 224 or PB1703
peptides (AusPep) for 5 hrs at 37uC, 5% CO2 in the presence of
1mg/ml Golgi-Plug (BD Biosciences Pharmingen) and 10U/ml
recombinant human IL-2 (Roche, Germany) (BD Biosciences).
Cells were washed twice with FACS buffer, stained with CD8-
PerCP Cy5.5 for 30 mins on ice, fixed, permeabilised and stained
with anti-IFN-c-FITC (5mg/ml), TNF-a-APC (2mg/ml), and IL-2-
PE (2mg/ml) mAbs (Biolegend). Samples were acquired using flow
cytometry, and the total cytokine production calculated by
subtracting background fluorescence using no peptide controls.
In selected experiments, lymphocytes were stimulated with varying
concentrations of peptides, three-fold dilutions ranging from
300nM to 0.0008nM to determine the sensitivity specific peptides,
defined as ‘functional avidity’ [52].
TCR avidity for pMHC complex by CD8b-dependence
Splenocytes were obtained from mice sampled on d6 after
secondary infection. Lymphocytes were pre-cultured in the
presence or absence of anti-CD8b antibody (53.5–8) (10 mg/ml).
Cells were then stimulated for 5 h with peptide, IL-2 and
GolgiStop also in the presence or absence of anti-CD8b antibody
(5 mg/ml). Following stimulation, cells were analysed for CD8 and
IFNc expression. Shown is the percentage of CD8
+ cells producing
IFN-c after stimulation in the presence of anti-CD8b blocking
mAb.
Determination of N3A366
+CD8
+ T cell precursor frequency
Naı ¨ve N3A366-specific CD8
+ T cells were identified as described
[33,53]. Briefly, processed lymph nodes and spleen samples were
resuspended in 100 ml of Sorter buffer, 100 ml FcR block (24G2
and CD16 culture supernatant, 1% mouse and 1% rat serum) was
added, and clumps of dead cells were discarded. Tetramers at
optimal staining concentrations (D
bN3A366-PE at 40mg/ml and
D
bNP366-PE at 10mg/ml) were added to the cell mix and
incubated for 1 hour at room temperature in the dark. Cells were
washed and resuspended in 400 ml buffer with 100 ml anti-PE
microbeads (Miltenyi Biotec), and incubated at 4uC for 25 mins.
Following two washes, cells were resuspended in 3 ml of buffer
and cells that had bound the microbeads were purified on a
magnetic LS column according to manufacturers instructions
(Miltenyi Biotec). Cells eluted from the column were centrifuged
(5156g, 6 min, 4uC), supernatant carefully aspirated to leave 90 ml
buffer remaining, and 10 ml antibody cocktail was added for
30 min at 4uC. The antibody cocktail contained anti-CD8-APC
Cy7 (Pharmingen, BD), anti-CD4-PE Cy7 (eBiosciences), anti-
B220-FITC (Pharmingen, BD), anti-CD11b-FITC (eBiosciences),
anti-CD11c-FITC (eBiosciences), anti-F4/80-FITC (eBiosciences),
anti-CD62L-APC (Pharmingen, BD), and anti-CD3-PerCP Cy5.5
(Pharmingen, BD) mAbs. Cells were washed in 2 ml buffer,
centrifuged (5156g, 6 min, 4uC), and supernatant aspirated
leaving 100 ml. Resuspended cells were passed through 45 mm
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Dickinson) and analysed with FlowJo (Treestar Inc.) software. In
selected experiments, naı ¨ve NPN3A
+Vb8.3
+CD8
+ T cells were
single-cell sorted for TCRb analysis. Experimental details of the
single cell RT-PCR designed to amplify naive NPN3A
+Vb8.3
+CD8
+
T cells using 2 different sorting strategies are listed in Table S3.
Hybridoma LacZ assay
LacZ-inducible T cell hybridomas specific for NP366 peptide
[37,54] were resuspended at 1610
6cell/mL and aliquots (100ml)
and dispensed into 96-well flat-bottom plates together with 5610
5
naı ¨ve splenocytes (APCs). Cells were cultured in the presence of
NP366 or NPN3A peptides at concentrations ranging from
10
215Mt o1 0
24M for 18h at 37
0C. The cells were then washed
with PBS, fixed with 100ml of 2% formaldehyde/0.2% glutaral-
dehyde in PBS for 5min on ice, washed in PBS and incubated with
2.5mg of 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-gal) for
16h at 37
0C. The LacZ
+ hybridomas were then counted using a
light microscope, and the number of NP366-specific hybridomas
was calculated by subtracting the ‘‘background’’ LacZ expression
for cells cultured in the absence of the peptide.
Isolation of single cell CD8
+ T cells, RT-PCR and
sequencing
Splenocytes were stained with 10 mg/ml D
bNP366 or 40 mg/ml
D
bN3A366-PE tetramer in sort buffer (PBS with 0.1% BSA) for
60 mins at room temperature, washed and stained with 1 mg/ml
anti-CD8-Allophycocyanin and 10 mg/ml of either anti-Vb 8.3
or anti-Vb9 for 30 mins on ice, washed twice with sort buffer.
Single lymphocytes were isolated by sorting with a FACS Aria
(BD Immunocytometry), into 80 wells of an empty 96 well twin-
tec plate (Eppendorf). mRNA transcripts were reversed tran-
scribed to cDNA, using a Sensiscript kit (Qiagen) according to
manufacturers instructions, and the CDR3b region amplified by
a nested hot start PCR using Vb primers [34]. Positive PCR
products were purified using Qiagen PCR purification kit and
sequenced.
Protein expression, purification, crystallisation and
structure determination
H2-D
b and b2-microglobulin molecules were expressed in
Escherichia Coli as inclusion bodies, refolded with the NP-N3A
(ASAENMETM) peptide and purified as previously described
[55,56]. The H2D
bNP-N3A complex crystals were obtained at
3mg/ml by the hanging-drop vapour diffusion technique at 20uC.
Crystals were grown with a reservoir containing 0.1 M sodium
citrate at pH 5.7, 28% PEG 3350 (w/v), 0.2 M lithium sulphate.
The crystals belong to space group I222 and the unit cell
dimensions were consistent with one molecule per asymmetric
units (Table S1).
The crystals were flash frozen to a temperature of 100K before
data collection in-house with a Rigaku RU-200 rotating-anode X-
ray generator. The data were processed and scaled with the XDS
[57]. The crystal structure was solved using the molecular
replacement method using the program Phaser [58] from the
CCP4 suite of programs [59]. The search probe used to solve the
structure was the structure of mouse MHC class I H2-D
b minus
the peptide (Protein Data Bank accession number 3CPL) [22].
The progress of refinement was monitored by the Rfree value with
neither a sigma nor a low-resolution cutoff being applied to the
data. The refinement protocol used includes several cycles of
refinement with REFMAC [59] followed by manual model
rebuilding with O program [60]. ‘Translation, liberation and
screw-rotation’ displacement refinement was used to model
anisotropic displacements of defined domains was used during
the refinement process. The electron density around the NPN3A
peptide was unambiguous, and all the side chains were built at full
occupancy. Some mobile loops in the heavy chain of the H-2D
b
molecule (residues 191–201; 220–228 and 247–254) have been
removed from the final model due to missing electronic density.
Final refinement statistics are summarized in Table I, the
coordinates of the H2Db-NP-N3A complex have been deposited
with the Protein Data Bank under accession numbers 3FTG.
Thermostability measurements of recombinant class I
complexes using circular dichroism (CD)
Circular Dichroism Spectra were measured on a Jasco 815
spectropolarimeter using a thermostatically controlled cuvette. A
far-UV spectra was collected from 190nm to 250nm. The UV
minimum was determined as 219 nm for H2Db-NP-N3A. The
measurements for the thermal melting experiments was made at
the minimum for H2Db-NP-N3A, at intervals of 0.1uC at a rate of
1uC/min from 20uCt o9 0 uC. The Jasco Spectra Manager
software was used to view and smooth the traces and then the
GraphPad Prism software was used to plot Temperature versus %
unfolded. The midpoint of thermal denaturation (Tm) for each
protein was determined as the point at which 50% unfolding was
achieved. The measurements were done in duplicate at two
concentrations (4mM and 2.2mM) in a solution of 10mM Tris
pH 8, 150mM NaCl.
Protein Data Bank accession number
The atomic coordinates have been deposited in the Protein
Data Bank, www.pdb.org (PDB ID code 3FTG).
Supporting Information
Figure S1 Phenotypic and functional characteristics of
NPN3A
+CD8
+ T cells. (A–D) Tetramer
+ CD8
+ T cells were
characterized for (A, B) CD62L and (C, D) IL-7Ra expression
following primary (A, C; d10) or secondary (B, D; d8) challenge.
(E–H) The ICS assay was used to measure cytokine production
following in vitro stimulation with the cognate peptide following
primary (E, G) or secondary (F, H) challenge for TNF-a
+ (E, F)
and IL-2
+ within the IFN-c
+ set (G, H). Data represent mean6SD
from 5 mice per group, *=p,0.01.
Found at: doi:10.1371/journal.ppat.1001039.s001 (2.47 MB
TIF)
Figure S2 TCR Vb usage in primary and secondary NPN3A
+
CD8
+ and D
bNP366
+CD8
+ T cell responses. Primary (A, C) or
secondary (B, D) responses were generated by infection with either
the (A, B) HK-NPN3A or (C, D) HK virus. Splenocytes were
stained with the (A, B) D
bNPN3A or (C, D) D
bNP366 tetramer,
anti-CD8 and anti-Vb mAbs conjugated with FITC, then the
tetramer
+CD8
+ cells were analysed for profiles of Vb staining.
Shown are results for (A–D) individual mice (n=4). S: spleen.
Found at: doi:10.1371/journal.ppat.1001039.s002 (1.33 MB TIF)
Figure S3 N3A substitution within NP366 does not affect antigen
presentation or the rate of viral clearance. Effects of N3A
substitution within NP366 on (A) viral clearance and (B, C) antigen
presentation was assessed. (A) Naı ¨ve mice were infected with either
the wt HK or mutant HK-NPN3A virus. Lungs were sampled at
days 3, 6, or 8 after infection and homogenized for virus titration
by plaque assay on MDCK cell monolayers. Data represent the
mean and n=5 mice per group. (B, C) ex vivo
51Cr-mediated
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b) EL-4
target cells either (B) infected with HK or HK-NPN3A virus or (C)
pulsed with 1mMN P 366 or NPN3A peptides.
Found at: doi:10.1371/journal.ppat.1001039.s003 (1.21 MB TIF)
Figure S4 Scatchard analysis of TCR avidity for pMHC by
tetramer dilution assay at the acute secondary time point (d8).
Scatchard analysis of tetramer dissociation and correlation
coefficient (R
2) based on tetramer binding MFI (Holmberg K et
al, J Immunol 171:2427, 2003) are shown. Memory mice primed
with either (A, D) PR8 or (B, C) PR8-NPN3A viruses were
challenged with either (A, D) HK or (B, C) mutant HK-NPN3A
virus. Data represent mean of MFI/tetramer concentration (mg/
ml) versus MFI of tetramer staining, from 4 mice per group.
Found at: doi:10.1371/journal.ppat.1001039.s004 (1.96 MB TIF)
Table S1 Summary of TCRb and TCRa repertoire for
D
bNP366 and D
bNPN3A Vb8.3
+ T cells following 1
0 and 2
0
infection with the wt or mutant NPN3A influenza virus
Found at: doi:10.1371/journal.ppat.1001039.s005 (0.05 MB
DOC)
Table S2 Frequency of TCRbsi nD
bNPN3A
+ Vb9
+CD8
+ T
cells after 1
0 mutant HK-NPN3A infection detected with either
the D
bNP366
+ or D
bNPN3A
+ tetramer
Found at: doi:10.1371/journal.ppat.1001039.s006 (0.05 MB
DOC)
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